Kristi Rosa | Authors


Phlebotomy Requirements Diminished With Rusfertide for Polycythemia Vera

June 15, 2021

The hepcidin mimetic rusfertide is suggested to reduce the need for phlebotomy in patients with polycythemia vera, according to the results of the phase 2 PTG-300-04 trial presented during the European Hematology Association 2021 Virtual Congress.